These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 27380339)
1. Deutetrabenazine for Treatment of Chorea in Huntington Disease. Geschwind MD; Paras N JAMA; 2016 Jul; 316(1):33-5. PubMed ID: 27380339 [No Abstract] [Full Text] [Related]
2. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. ; Frank S; Testa CM; Stamler D; Kayson E; Davis C; Edmondson MC; Kinel S; Leavitt B; Oakes D; O'Neill C; Vaughan C; Goldstein J; Herzog M; Snively V; Whaley J; Wong C; Suter G; Jankovic J; Jimenez-Shahed J; Hunter C; Claassen DO; Roman OC; Sung V; Smith J; Janicki S; Clouse R; Saint-Hilaire M; Hohler A; Turpin D; James RC; Rodriguez R; Rizer K; Anderson KE; Heller H; Carlson A; Criswell S; Racette BA; Revilla FJ; Nucifora F; Margolis RL; Ong M; Mendis T; Mendis N; Singer C; Quesada M; Paulsen JS; Brashers-Krug T; Miller A; Kerr J; Dubinsky RM; Gray C; Factor SA; Sperin E; Molho E; Eglow M; Evans S; Kumar R; Reeves C; Samii A; Chouinard S; Beland M; Scott BL; Hickey PT; Esmail S; Fung WL; Gibbons C; Qi L; Colcher A; Hackmyer C; McGarry A; Klos K; Gudesblatt M; Fafard L; Graffitti L; Schneider DP; Dhall R; Wojcieszek JM; LaFaver K; Duker A; Neefus E; Wilson-Perez H; Shprecher D; Wall P; Blindauer KA; Wheeler L; Boyd JT; Houston E; Farbman ES; Agarwal P; Eberly SW; Watts A; Tariot PN; Feigin A; Evans S; Beck C; Orme C; Edicola J; Christopher E JAMA; 2016 Jul; 316(1):40-50. PubMed ID: 27380342 [TBL] [Abstract][Full Text] [Related]
4. Deutetrabenazine for the treatment of Huntington's chorea. Bashir H; Jankovic J Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061 [TBL] [Abstract][Full Text] [Related]
5. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979 [TBL] [Abstract][Full Text] [Related]
6. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea. Frank S; Stamler D; Kayson E; Claassen DO; Colcher A; Davis C; Duker A; Eberly S; Elmer L; Furr-Stimming E; Gudesblatt M; Hunter C; Jankovic J; Kostyk SK; Kumar R; Loy C; Mallonee W; Oakes D; Scott BL; Sung V; Goldstein J; Vaughan C; Testa CM; JAMA Neurol; 2017 Aug; 74(8):977-982. PubMed ID: 28692723 [TBL] [Abstract][Full Text] [Related]
7. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review. Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372 [TBL] [Abstract][Full Text] [Related]
8. The long-term effect of tetrabenazine in the management of Huntington disease. Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408 [TBL] [Abstract][Full Text] [Related]
9. Real-World Experience With Deutetrabenazine for Huntington Disease Chorea. Curtis K; Sung V J Clin Pharmacol; 2024 Feb; 64(2):178-181. PubMed ID: 37565322 [TBL] [Abstract][Full Text] [Related]
10. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease. Heo YA; Scott LJ Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203 [TBL] [Abstract][Full Text] [Related]
11. Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome. Paton DM Drugs Today (Barc); 2017 Feb; 53(2):89-102. PubMed ID: 28387387 [TBL] [Abstract][Full Text] [Related]
12. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine. Setter SM; Neumiller JJ; Dobbins EK; Wood L; Clark J; DuVall CA; Santiago A Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181 [TBL] [Abstract][Full Text] [Related]
13. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Chen JJ; Ondo WG; Dashtipour K; Swope DM Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259 [TBL] [Abstract][Full Text] [Related]
14. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease. Dean M; Sung VW Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277 [TBL] [Abstract][Full Text] [Related]
16. An experimental model for Huntington's chorea? Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685 [TBL] [Abstract][Full Text] [Related]
17. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators. Frank S BMC Neurol; 2009 Dec; 9():62. PubMed ID: 20021666 [TBL] [Abstract][Full Text] [Related]